« Previous
Next »
Seminars in Thoracic and Cardiovascular Surgery
Volume 17, Issue 4
, Pages 343-347
, Winter 2005
Gene Therapy for Heart Failure
References
- Hope for a broken heart? . Trends Biotechnol . 2004;22:487–489
- . Gene therapy targeted at calcium handling as an approach to the treatment of heart failure . Pharmacol Ther . 2005;105:211–228
- A randomized controlled trial of epoprostenol therapy for severe congestive heart failure (the flolan international randomized survival trial (FIRST)) . Am Heart J . 1997;134:44–54
- Effect of carvedilol on survival in severe chronic heart failure . N Engl J Med . 2001;344:1651–1658
-
Comparison of candesartan, enalapril, and their combination in congestive heart failure
(randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study)
.
Circulation
. 1999;100:1056–1064
- . The cardiac insufficiency bisoprolol study II (CIBIS-II). A randomised trial . Lancet . 1999;353:9–13
- Cardiac resynchronization in chronic heart failure . N Engl J Med . 2002;346:1845–1853
- Long-term mechanical left ventricular assistance for end-stage heart failure . N Engl J Med . 2001;345:1435–1443
- The registry of the international society for heart and lung transplantation (eighteenth official report-2001) . J Heart Lung Transplant . 2001;20:805–815
- Nucleic acid-based modulation of cardiac gene expression for the treatment of cardiac diseases. approaches and perspectives . Z Kardiol . 2004;93:171–193
- betaARK1 inhibition improves survival in a mouse model of heart failure induced by myocardial infarction . J Cardiovasc Pharmacol . 2004;44:329–334
- . Why does the myocardium fail? Insights from basic science . Lancet . 1998;352(suppl 1):SI8–SI14
-
RockmanHA, Koch WJ, Lefkowitz RJ: Seven-transmembrane-spanning receptors and heart function. Nature 415:206212, 200.
- Potentiation of beta-adrenergic signaling by adenoviral-mediated gene transfer in adult rabbit ventricular myocytes . J Clin Invest . 1997;99:288–296
-
Expression of a beta-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice
.
Proc Natl Acad Sci USA
. 1998;95:7000–7005
- Alterations in cardiac adrenergic signaling and calcium cycling differentially affect the progression of cardiomyopathy . J Clin Invest . 2001;107:967–974
- Ventricular dysfunction after cardioplegic arrest is improved after myocardial gene transfer of a beta-adrenergic receptor kinase inhibitor . Circulation . 2001;104:2069–2074
-
Preservation of myocardial beta-adrenergic receptor signaling delays the development of heart failure after myocardial infarction
.
Proc Natl Acad Sci USA
. 2000;97:5428–5433
-
In vivo ventricular gene delivery of a beta-adrenergic receptor kinase inhibitor to the failing heart reverses cardiac dysfunction
.
Circulation
. 2001;103:1311–1316
- Targeted beta-adrenergic receptor kinase (betaARK1) inhibition by gene transfer in failing human hearts . Circulation . 2004;109:1590–1593
- Intracoronary adenovirus encoding adenylyl cyclase VI increases left ventricular function in heart failure . Circulation . 2004;110:330–336
- . Adenylyl cyclase (a new target for heart failure therapeutics) . Circulation . 2002;105:1876–1878
- . Beta-adrenergic receptors and receptor signaling in heart failure . Annu Rev Pharmacol Toxicol . 1999;39:343–360
-
Quantification of signalling components and amplification in the beta-adrenergic-receptor-adenylate cyclase pathway in isolated adult rat ventricular myocytes
.
Biochem J
. 1995;311(Pt. 1):75–80
-
Cardiac-directed adenylyl cyclase expression improves heart function in murine cardiomyopathy
.
Circulation
. 1999;99:3099–3102
- Adenylyl cyclase increases survival in cardiomyopathy . Circulation . 2002;105:1989–1994
- Indirect intracoronary delivery of adenovirus encoding adenylyl cyclase increases left ventricular contractile function in mice . Am J Physiol Heart Circ Physiol . 2004;287:H172–H177
-
Intracoronary delivery of adenovirus encoding adenylyl cyclase VI increases left ventricular function and cAMP-generating capacity
.
Circulation
. 2000;102:2396–2401
- . Electrophysiological remodeling in hypertrophy and heart failure . Cardiovasc Res . 1999;42:270–283
- . Calcium cycling in congestive heart failure . J Mol Cell Cardiol . 2002;34:951–969
- . Targeting calcium cycling proteins in heart failure through gene transfer . J Physiol . 2003;546:49–61
-
Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure
.
Proc Natl Acad Sci USA
. 2000;97:793–798
- Improvement in survival and cardiac metabolism after gene transfer of sarcoplasmic reticulum ca(2+)-ATPase in a rat model of heart failure . Circulation . 2001;104:1424–1429
-
Restoration of diastolic function in senescent rat hearts through adenoviral gene transfer of sarcoplasmic reticulum ca(2+)-ATPase
.
Circulation
. 2000;101:790–796
- Comparative analysis of parvalbumin and SERCA2a cardiac myocyte gene transfer in a large animal model of diastolic dysfunction . Am J Physiol Heart Circ Physiol . 2004;286:H2314–H2321
-
Tight control of exogenous SERCA expression is required to obtain acceleration of calcium transients with minimal cytotoxic effects in cardiac myocytes
.
Circ Res
. 2001;88:415–421
- . Molecular regulation of phospholamban function and expression . Trends Cardiovasc Med . 1998;8:330–340
- Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery . Nat Med . 2002;8:864–871
- Chronic phospholamban inhibition prevents progressive cardiac dysfunction and pathological remodeling after infarction in rats . J Clin Invest . 2004;113:727–736
-
.
Sites of regulatory interaction between calcium ATPases and phospholamban
.
Ann NY Acad Sci
. 1998;853:31–42
-
Effects of mutant and antisense RNA of phospholamban on SR ca(2+)-ATPase activity and cardiac myocyte contractility
.
Circulation
. 1999;100:974–980
-
Adenovirus-based phospholamban antisense expression as a novel approach to improve cardiac contractile dysfunction
(comparison of a constitutive viral versus an endothelin-1-responsive cardiac promoter)
.
Circulation
. 2000;101:2193–2199
- Targeting phospholamban by gene transfer in human heart failure . Circulation . 2002;105:904–907
-
A recombinant antibody increases cardiac contractility by mimicking phospholamban phosphorylation
.
FASEB J
. 2004;18:1312–1314
-
.
Models of dilated cardiomyopathy in small animals and novel positive inotropic therapies
.
Ann NY Acad Sci
. 2004;1015:320–331
-
.
Parvalbumin gene transfer corrects diastolic dysfunction in diseased cardiac myocytes
.
Proc Natl Acad Sci USA
. 1999;96:11982–11985
- In vivo acceleration of heart relaxation performance by parvalbumin gene delivery . J Clin Invest . 2001;107:191–198
- Gene transfer of parvalbumin improves diastolic dysfunction in senescent myocytes . Circulation . 2004;109:2780–2785
- Altered expression of the ca(2+)-binding protein S100A1 in human cardiomyopathy . Biochim Biophys Acta . 1996;1313:253–257
- Cardiac adenoviral S100A1 gene delivery rescues failing myocardium . J Clin Invest . 2004;114:1550–1563
- Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart . Nat Med . 1996;2:534–539
- Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector . Nat Genet . 2000;24:257–261
-
.
New insight into the role of enhanced adrenergic receptor-effector coupling in the heart
.
Circulation
. 1999;100:579–582
PII: S1043-0679(05)00072-9
doi: 10.1053/j.semtcvs.2005.09.002
© 2005 Elsevier Inc. All rights reserved.
« Previous
Next »
Seminars in Thoracic and Cardiovascular Surgery
Volume 17, Issue 4
, Pages 343-347
, Winter 2005
